The Oncology Institute, Inc. TOI Other Current Liabilities
Other Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherSundryLiabilitiesCurrent.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s other current liabilities?
- The Oncology Institute, Inc. (TOI) reported other current liabilities of $5.67M in Q1 2026.
- How has The Oncology Institute, Inc.'s other current liabilities changed year-over-year?
- The Oncology Institute, Inc.'s other current liabilities decreased by 25.7% year-over-year, from $7.63M to $5.67M.
- What is the long-term trend for The Oncology Institute, Inc.'s other current liabilities?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s other current liabilities has grown at a 9.7% compound annual growth rate (CAGR), from $2.97M to $4.31M.
- What does other current liabilities mean?
- Miscellaneous current obligations not classified in specific categories — a catch-all for short-term liabilities.